eScholarship
metadata only
A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.
BACKGROUND: Psilocybin, a serotonergic psychedelic found in hallucinogenic mushrooms, is metabolized to psilocin, the compound responsible for its psychoactive effects. Psilocybin has demonstrated therapeutic potential for neuropsychiatric conditions. While recent trials have primarily used orally a
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids#994315
- A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.#850787
- Effect of SSRIs on Response to Psilocybin Therapy#878096
- A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.#415616
- Trial of Cannabis for Essential Tremor#904219
Record · ID 1079042
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive